Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 224

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines

Open access
Neilan, Tomas G., Coelho-Filho, Otavio R., Pena-Herrera, Diego, Shah, Ravi V., Jerosch-Herold, Michael, Francis, Sanjeev A., Moslehi, Javid, Kwong, Raymond Y. · 2012 · The American Journal of Cardiology

Abstract

We aimed to describe the cardiac magnetic resonance (CMR) findings and to determine prognostic variables in patients with a cardiomyopathy after treatment with anthracyclines. CMR imaging was performed in 91 patients (58% male, mean age of 43 ± 18 years and anthracycline dose of 276 ± 82 mg/m2) with reduced ejection fraction (EF) after anthracycline-based chemotherapy. Major adverse cardiovascular events (MACE) were defined as cardiovascular death, appropriate implantable cardioverter defibrillator therapy, and admission for decompensated heart failure. Patients presented a median of 88 months (IQR 37 to 138) after chemotherapy and were followed for 27 months (IQR 22 to 38). Late gadolinium enhancement was an uncommon finding (5 patients, 6%) despite a reduced EF (36 ± 8%). There was an inverse association between anthracycline dose and the indexed left ventricular (LV) mass by CMR (r = −0.67, p < 0.001). There were 52 adverse cardiac events (event rate of 22% per year). When patients were grouped according to the presence or absence of a MACE, indexed LV mass and glomerular filtration rate were lower and anthracycline dose was higher among patients that experienced an adverse event. In a multivariable model, indexed LV mass demonstrated the strongest association with MACE (HR = 0.89, chi-squared = 26, p < 0.001). In conclusion, scar by LGE-CMR imaging is infrequent in patients with an anthracycline-induced cardiomyopathy despite a reduced EF, the event rate in patients with an established anthracycline-induced cardiomyopathy is high, and indexed LV-mass by CMR is a predictor of adverse cardiovascular events.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2012.07.040

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 224

Metadata

Authors
Neilan, T. G., Coelho-Filho, O. R., Pena-Herrera, D., Shah, R. V., Jerosch-Herold, M., Francis, S. A., Moslehi, J., & Kwong, R. Y.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2012-12
Volume
110
Issue
11
Pages
1679-1686
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2167777123
Cited by
224
References
2
FWCI
4.60
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.